1. Home
  2. ICCC vs MOVE Comparison

ICCC vs MOVE Comparison

Compare ICCC & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • MOVE
  • Stock Information
  • Founded
  • ICCC 1982
  • MOVE 2018
  • Country
  • ICCC United States
  • MOVE United States
  • Employees
  • ICCC N/A
  • MOVE N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ICCC Health Care
  • MOVE Health Care
  • Exchange
  • ICCC Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • ICCC 28.0M
  • MOVE 25.9M
  • IPO Year
  • ICCC 1987
  • MOVE 2021
  • Fundamental
  • Price
  • ICCC $3.66
  • MOVE $3.18
  • Analyst Decision
  • ICCC
  • MOVE Buy
  • Analyst Count
  • ICCC 0
  • MOVE 1
  • Target Price
  • ICCC N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • ICCC 14.5K
  • MOVE 63.3K
  • Earning Date
  • ICCC 11-13-2024
  • MOVE 11-14-2024
  • Dividend Yield
  • ICCC N/A
  • MOVE N/A
  • EPS Growth
  • ICCC N/A
  • MOVE N/A
  • EPS
  • ICCC N/A
  • MOVE N/A
  • Revenue
  • ICCC $23,838,002.00
  • MOVE $902,000.00
  • Revenue This Year
  • ICCC N/A
  • MOVE N/A
  • Revenue Next Year
  • ICCC N/A
  • MOVE $443.49
  • P/E Ratio
  • ICCC N/A
  • MOVE N/A
  • Revenue Growth
  • ICCC 46.37
  • MOVE N/A
  • 52 Week Low
  • ICCC $3.34
  • MOVE $2.80
  • 52 Week High
  • ICCC $5.59
  • MOVE $14.70
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 54.28
  • MOVE 34.68
  • Support Level
  • ICCC $3.40
  • MOVE $3.76
  • Resistance Level
  • ICCC $3.64
  • MOVE $3.30
  • Average True Range (ATR)
  • ICCC 0.16
  • MOVE 0.32
  • MACD
  • ICCC 0.01
  • MOVE -0.07
  • Stochastic Oscillator
  • ICCC 65.12
  • MOVE 20.99

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: